NEW YORK (GenomeWeb News) — Third Wave Japan, a subsidiary of Third Wave Technologies, has raised roughly $5.3 million in a stock placement, the company stated in a filing with the Securities and Exchange Commission yesterday.
 
Third Wave Japan sold 7,112 shares of common stock at ¥90,000 ($743) per share to Mitsubishi, Shimadzu, CSK Institute for Sustainability, Daiichi Pure Chemicals, BML, and Toppan Printing.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.